Cargando…

Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Due to drug-induced potential congestive heart failure and irreversible dilated cardiomyopathies, preclinical evaluation of cardiac dysfunction is important to assess the safety of traditional or novel treatments. The embryos of Nelumbo nucifera Gaertner seeds are a homology of traditional Chinese m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yangyang, Sun, Shennan, Wang, Shifeng, Zhang, Qiao, Li, Ming, Lan, Feng, Li, Shiyou, Liu, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783920/ https://www.ncbi.nlm.nih.gov/pubmed/26840304 http://dx.doi.org/10.3390/ijms17020186

Ejemplares similares

Liensinine and neferine exert neuroprotective effects via the autophagy pathway in transgenic Caenorhabditis elegans
por: Wu, Meng-chen, et al.
Publicado: (2023)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
por: Maillet, Agnes, et al.
Publicado: (2016)

Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Huang, Mo-Fan, et al.
Publicado: (2021)

Modelling cadmium‐induced cardiotoxicity using human pluripotent stem cell‐derived cardiomyocytes
por: Shen, Jiaxi, et al.
Publicado: (2018)

Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020)

Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lu, Jun, et al.
Publicado: (2014)

Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes
por: Zhao, Qi, et al.
Publicado: (2017)

Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
por: Liu, Rui, et al.
Publicado: (2020)

Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
por: Chaudhari, Umesh, et al.
Publicado: (2017)

Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes
por: Christidi, Effimia, et al.
Publicado: (2020)

Characterization of the molecular mechanisms underlying azithromycin‐induced cardiotoxicity using human‐induced pluripotent stem cell‐derived cardiomyocytes
por: Wang, Xiaochen, et al.
Publicado: (2021)

Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
por: Sachinidis, Agapios
Publicado: (2020)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
por: Grafton, Francis, et al.
Publicado: (2021)

Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
por: Narkar, Akshay, et al.
Publicado: (2022)

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products
por: Simms, Liam, et al.
Publicado: (2022)

Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes
por: Cao, Lu, et al.
Publicado: (2020)

Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes
por: Chu, Axel J., et al.
Publicado: (2020)

Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity
por: Ma, Wanjun, et al.
Publicado: (2020)

Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
por: Bozza, William P., et al.
Publicado: (2021)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
por: Hamledari, Homa, et al.
Publicado: (2022)

Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity
por: Song, Yuanxiu, et al.
Publicado: (2022)

Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes
por: Lee, Hyang-Ae, et al.
Publicado: (2018)

In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts
por: Kadota, Shin, et al.
Publicado: (2017)

Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lee, Yee-Ki, et al.
Publicado: (2011)

Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
por: Itzhaki, Ilanit, et al.
Publicado: (2011)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes
por: Kido, Koji, et al.
Publicado: (2017)

Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
por: Machiraju, Pranav, et al.
Publicado: (2019)

Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes
por: Wu, Peng, et al.
Publicado: (2021)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues
por: Xu, He, et al.
Publicado: (2022)

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Zhao, Zhihan, et al.
Publicado: (2018)

Uses of cardiomyocytes generated from induced pluripotent stem cells
por: Lu, Tung-Ying, et al.
Publicado: (2011)

Aconitine-induced cardiac arrhythmia in human induced pluripotent stem cell-derived cardiomyocytes
por: Zhang, Feng, et al.
Publicado: (2018)

Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Yuecel, Goekhan, et al.
Publicado: (2023)

Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes
por: Kim, Ye Seul, et al.
Publicado: (2020)

Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes
por: Yücel, Gökhan, et al.
Publicado: (2017)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
por: Li, Jiangtao, et al.
Publicado: (2022)

Excitation–contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes
por: Kane, Christopher, et al.
Publicado: (2015)

Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes
por: Lei, Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b0o6fib4m4ldc5ieghmfle1rbn